Soluble Vascular Endothelial Growth Factor Receptor 1(sFlt-1/sVEGFR-1) (N-Term) Antikörper
-
- Target
- Soluble Vascular Endothelial Growth Factor Receptor 1(sFlt-1/sVEGFR-1)
- Bindungsspezifität
- N-Term
- Reaktivität
- Human
- Wirt
- Kaninchen
- Klonalität
- Polyklonal
- Applikation
- ELISA, Immunofluorescence (IF), Western Blotting (WB)
- Spezifität
- Reacts with human FLT1 protein
- Kreuzreaktivität
- Maus
- Kreuzreaktivität (Details)
- Cross reacts with mouse and other species
- Aufreinigung
- Antiserum
- Immunogen
- Synthetic peptide derived from Nter domain of human FLT1 protein
- Isotyp
- IgG
-
- Applikationshinweise
-
Working dilution: Optimal dilution should be determined by the end user.
The following are guidelines only :
IF(1:50 - 1:200) WB(1:100 - 1:1000) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Must be reconstituted in distilled water.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Lyophilized powder stable for a minimum of 2 years at -20°C. Store reconstituted antibodies at +4°C. For extended periods store in aliquots at -20°C. Antibodies are guaranteed for 6 month from date of receipt.
- Haltbarkeit
- 24 months
-
- Target
- Soluble Vascular Endothelial Growth Factor Receptor 1(sFlt-1/sVEGFR-1)
- Andere Bezeichnung
- Soluble Vascular Endothelial Growth Factor Receptor-1, FLT1/VEGFR-1
- UniProt
- P17948
-